8-K: Equus Total Return, Inc. Secures $2 Million Investment via Convertible Note; Invests $1.5 Million in General Enterprise Ventures

Equus Total Return, Inc. has entered into agreements for a $2 million convertible note and a $1.5 million investment in General Enterprise Ventures, Inc.

Summary

• Equus Total Return, Inc. entered into a Securities Purchase Agreement on February 10, 2025, for a $2.0 million, 1-year senior convertible promissory note with a 10.0% annual interest rate.
• The Equus Note is convertible into common stock at $1.50 per share.
• Equus also issued warrants to acquire 2,000,000 shares of its common stock at an exercise price of $1.50 per share.
• On the same date, Equus entered into a Subscription Agreement with General Enterprise Ventures, Inc. (GEVI) to purchase a $1.5 million, 1-year senior convertible promissory note with a 10% annual interest rate.
• The GEVI Note is convertible into GEVI's common stock at $0.40 per share.
• Equus also received a warrant to acquire 1,875,000 shares of GEVI common stock at an exercise price of $0.50 per share.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. Equus is securing funding and making a strategic investment, which are generally positive developments. However, the potential dilution from the convertible notes and the risks associated with the GEVI investment temper the overall sentiment.

Positives

• Equus Total Return, Inc. has secured $2.0 million in funding.
• Equus has the potential to benefit from its investment in GEVI through stock conversion and warrant exercise.

Risks

• The convertible notes could dilute existing Equus shareholders if converted.
• The success of the investment in GEVI depends on GEVI's performance.
• The resale of the Convertible Note and the Warrant purchased by the undersigned pursuant to this Subscription Agreement in violation of the Act or any other applicable law.

Future Outlook

The document does not contain specific forward-looking statements beyond the transactions themselves.

Industry Context

This announcement reflects a common strategy for investment firms to raise capital and make strategic investments in other companies, often utilizing convertible notes and warrants to structure the deals.

Comparison to Industry Standards

• Convertible notes with warrants are a fairly standard financing tool used by small and medium sized companies.
• The interest rates and conversion prices appear to be within market norms for similar types of transactions, but would require further analysis of the specific companies and market conditions to fully assess.
• Comparable companies that have used similar financing structures include Main Street Capital and Prospect Capital, both of which are BDCs that frequently use debt and equity investments.

Stakeholder Impact

• Shareholders may experience dilution if the convertible notes are converted into equity.
• GEVI may benefit from the $1.5 million investment from Equus.

Next Steps

• Equus will issue the Equus Note and Warrants.
• Equus will purchase the GEVI Note and receive the GEVI Warrant.
• The company shall either inform the stockholders of the Company of the receipt of the Stockholder Consent by preparing and filing with the SEC, as promptly as practicable after the date hereof, but prior to the [seventy-fifth (75th)] calendar day after the Subscription Date (or, if such filing is delayed by a court or regulatory agency, in no event later than [ninety (90) calendar days] after the Subscription Date), an information statement with respect thereto or provide each stockholder entitled to vote at a special or annual meeting of stockholders of the Company (the Stockholder Meeting) for the purpose of approving the issuance of in excess of 19.99% of the Companys outstanding shares of Common Stock pursuant to the Transaction Documents, which shall be promptly called and held not later than the [ninetieth (90th)] calendar day after the Subscription Date (the Stockholder Meeting Deadline), a proxy statement, in each case, in a form reasonably acceptable to the undersigned, at the expense of the Company.

Key Dates